Home-based Exercise for Management of HIV-associated Cardiovascular Disease Risk
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01377064|
Recruitment Status : Completed
First Posted : June 20, 2011
Last Update Posted : December 12, 2013
|Condition or disease||Intervention/treatment||Phase|
|Cardiovascular Diseases Hyperlipidemia Obesity||Behavioral: Physical Activity Group Other: Standard Care Group||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Home-based Exercise for Management of HIV-associated Cardiovascular Disease|
|Study Start Date :||March 2011|
|Actual Primary Completion Date :||July 2013|
|Actual Study Completion Date :||July 2013|
Experimental: Physical activity group
Subjects will participant in physical activity program
Behavioral: Physical Activity Group
9 months of home based physical activity meeting HHS recommendations for physical activity for all americans
Active Comparator: Standard care group
This group will not receive a physical activity intervention
Other: Standard Care Group
No intervention, the group will be followed under their standard medical care.
- Amount of Physical Activity [ Time Frame: 9 months ]Accelerometer data will be the primary means of determining the participants' physical activity levels. Participants will be instructed to wear the accelerometer at baseline, 4 months, and 9 months. The participants will be required to wear the accelerometer during the waking hours for seven consecutive days. Data from participants with at least four days and at least 10 hours per day will be included.
- Cardiorespiratory Fitness [ Time Frame: 9 months ]Each participant will complete a graded exercise stress test (GXT) with indirect calorimetry. This test will be used to screen for abnormal physiological responses to exercise and for determining the participant's maximal ability to utilize oxygen (an index of cardiorespiratory fitness).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01377064
|United States, South Carolina|
|Charleston, South Carolina, United States, 29425|
|University of South Carolina|
|Columbia, South Carolina, United States, 29208|